Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Macrogenics (NQ: MGNX )

8.660 +0.020 (+0.23%)
Streaming Delayed Price Updated: 10:54 AM EST, Dec 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 58,127
Open 8.700
Bid (Size) 8.660 (4)
Ask (Size) 8.700 (6)
Prev. Close 8.640
Today's Range 8.530 - 8.770
52wk Range 4.290 - 8.800
Shares Outstanding 61,107,288
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2 study results in the Annals of General Psychiatry. 
Via Benzinga
Datadog, Tripadvisor, Myriad Genetics, Planet Fitness And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded mostly higher, with the Nasdaq Composite gaining around 50 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities

Performance

YTD
+36.16%
+36.16%
1 Month
+59.19%
+59.19%
3 Month
+66.86%
+66.86%
6 Month
+64.95%
+64.95%
1 Year
+42.67%
+42.67%

More News

Read More
Earnings Scheduled For November 6, 2023
Via Benzinga
A Preview Of Macrogenics's Earnings
Via Benzinga
Why Shares of MacroGenics Are Jumping Thursday
Via The Motley Fool
MacroGenics (MGNX) Q3 2023 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
MacroGenics to Participate in Upcoming Investor Conferences
From MacroGenics, Inc.
Via GlobeNewswire
MacroGenics Announces Date of Third Quarter 2023 Financial Results Conference Call
From MacroGenics, Inc.
Via GlobeNewswire
Elli Lilly Joins Big Pharma’s Multi-Billion-Dollar Oncology Race
Via PressReach
MacroGenics (MGNX) Q1 2023 Earnings Call Transcript
Via The Motley Fool
MacroGenics Announces Achievement of $15 Million Milestone Related to Gilead’s Nomination of a Bispecific Research Program
From MacroGenics, Inc.
Via GlobeNewswire
MacroGenics to Participate in Upcoming Investor Conferences
From MacroGenics, Inc.
Via GlobeNewswire
3 Under-the-Radar Biotech Stocks to Buy in 2023
Via The Motley Fool
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Recap: Macrogenics Q1 Earnings
Via Benzinga
Earnings Outlook For Macrogenics
Via Benzinga
Why Krispy Kreme Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Disinflation Talk Grows, Rate Hike Bets Plummet: Top 5 ETFs Rallying On CPI Miss
Via Benzinga
Topics ETFs Economy
Exposures Interest Rates
Alibaba, Illumina, CyberArk Software And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Topics Stocks
Exposures US Equities
MacroGenics (MGNX) Q2 2023 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
MacroGenics Announces Date of Second Quarter 2023 Financial Results Conference Call
From MacroGenics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
MacroGenics Announces Date of First Quarter 2023 Financial Results Conference Call
From MacroGenics, Inc.
Via GlobeNewswire
MacroGenics to Participate in Upcoming Investor Conferences
From MacroGenics, Inc.
Via GlobeNewswire
Why Tupperware Brands Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.